Publications by authors named "Turley H"

Article Synopsis
  • - Current biomarkers for assessing the risk of tumor progression in ER-negative breast cancer patients are inadequate, prompting a study on the role of the AIPL1-NUB1 pathway in tumor suppression under hypoxic conditions.
  • - The study found that downregulation of AIPL1 leads to the deactivation of NUB1, observed through in vitro tests using breast cancer cell lines, and analysis of patient samples revealed significant differences in protein expression levels.
  • - Ultimately, lower levels of cytoplasmic NUB1 were linked to poorer overall survival rates in patients, indicating that both NUB1 and AIPL1 may play crucial roles in the prognosis of breast cancer, particularly in ER-negative cases.
View Article and Find Full Text PDF

Background: Malaria and schistosomiasis present considerable disease burden in tropical and sub-tropical areas and severity is worsened by co-infections in areas where both diseases are endemic. Although pathogenesis of these infections separately is well studied, there is limited information on the pathogenic disease mechanisms and clinical disease outcomes in co-infections. In this study, we investigated the prevalence of malaria and schistosomiasis co-infections, and the hematologic and blood chemistry abnormalities in asymptomatic adults in a rural fishing community in western Kenya.

View Article and Find Full Text PDF
Article Synopsis
  • DLL4 and JAG1 are two important molecules in tumors that help form blood vessels, but they act in opposite ways in mice.
  • Both of these molecules make tumor blood vessels grow, but DLL4 makes fewer, larger vessels while JAG1 makes more, smaller vessels.
  • Targeting DLL4 and JAG1 together may be an effective way to treat tumors by stopping them from growing and improving blood flow in the tumors.
View Article and Find Full Text PDF

Herein, we utilize surface-enhanced hyper-Raman scattering (SEHRS) under resonance conditions to probe the adsorbate geometry of rhodamine 6G (R6G) on silver colloids. Our results show resonance SEHRS is highly sensitive to molecular orientation due to non-Condon effects, which do not appear in its linear counterpart surface-enhanced Raman scattering. Comparisons between simulated and measured SEHRS spectra reveal R6G adsorbs mostly perpendicular to the nanoparticle surface along the ethylamine groups with the xanthene ring oriented edgewise.

View Article and Find Full Text PDF

Data on sepsis prevalence on the general wards is lacking on the UK and in the developed world. We conducted a multicentre, prospective, observational study of the prevalence of patients with sepsis or severe sepsis on the general wards and Emergency Departments (ED) in Wales. During the 24-hour study period all patients with NEWS≥3 were screened for presence of 2 or more SIRS criteria.

View Article and Find Full Text PDF

Objective: To develop a secure, efficient, and easy-to-use data collection platform to measure the prevalence of sepsis in Wales over 24 hours.

Materials And Methods: Open Data Kit was used on Android devices with Google App Engine and a digital data collection form.

Results: A total of 184 students participated in the study using 59 devices across 16 hospitals, 1198 datasets were submitted, and 97% of participants found the Open Data Kit form easy to use.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with encapsulated colorectal liver metastases (CRLM) show better prognosis compared to those with infiltrative types, which is linked to differences in tumor characteristics.
  • The study focused on 30 patients who had not received prior chemotherapy and assessed tumor markers, finding that encapsulated tumors had higher expression of HIF-1α, CA-9, and VEGF but lower microvascular density.
  • Long-term survival data indicated that those with encapsulated CRLM had significantly improved overall and 5-year survival rates compared to infiltrative CRLM patients.
View Article and Find Full Text PDF
Article Synopsis
  • * Severe hypoxia (around 0.1% oxygen) was found to increase glycolytic flux rates in tumor spheroids, enhancing the breakdown of glucose for energy despite limited oxygen.
  • * Under these severe conditions, while some key metabolic enzymes decreased in function, the presence of Hif1 and other factors helped maintain glycolysis, demonstrating a unique tumor adaptation to extreme hypoxic stress.
View Article and Find Full Text PDF

Motivated to explore the ultimate limits of surface-enhanced nonlinear spectroscopies, we report on the first observation of molecular second hyper-Raman scattering with the aid of surface enhancement and provide a new theoretical framework for first-principles calculations of the second hyper-Raman effect. Second hyper-Raman enhancement factors, determined to be a minimum of 10(5) times stronger than those in Raman scattering, demonstrate a clear trend toward larger enhancements for nonlinear phenomena, and the nearly quantitative agreement between simulation and experiment provides a unique spectroscopic window into higher-order molecular responses.

View Article and Find Full Text PDF

Tumour cells can use strategies that make them resistant to nutrient deprivation to outcompete their neighbours. A key integrator of the cell's responses to starvation and other stresses is amino-acid-dependent mechanistic target of rapamycin complex 1 (mTORC1). Activation of mTORC1 on late endosomes and lysosomes is facilitated by amino-acid transporters within the solute-linked carrier 36 (SLC36) and SLC38 families.

View Article and Find Full Text PDF

Antibodies are widely exploited as research/diagnostic tools and therapeutics. Despite providing exciting research opportunities, the multitude of available antibodies also offers a bewildering array of choice. Importantly, not all companies comply with the highest standards, and thus many reagents fail basic validation tests.

View Article and Find Full Text PDF

Background: Histone to protamine exchange and the hyperacetylation of the remaining histones are hallmarks of spermiogenesis. Acetylation of histone H4 at lysine 12 (H4K12ac) was observed prior to full decondensation of sperm chromatin after fertilization suggesting an important role for the regulation of gene expression in early embryogenesis. Similarly, DNA methylation may contribute to gene silencing of several developmentally important genes.

View Article and Find Full Text PDF

This study was undertaken to investigate the associations of blood vessel invasion (BVI), lymphatic vessel invasion (LVI) or other variables and long-term survival in 173 Japanese and 184 British patients with primary invasive breast cancer, and whether they are associated with survival differences between Japanese and British patients. BVI was detected by objective methods, using both factor VIII-related antigen (F-VIII) staining and elastica van Gieson (E v G) staining. BVI was classified into three subtypes.

View Article and Find Full Text PDF

Purpose: To assess whether the combination of letrozole, metronomic cyclophosphamide and sorafenib (LCS) is well tolerated and shows activity in primary breast cancer (BC).

Methods: Thirteen oestrogen receptor-positive, postmenopausal, T2-4, N0-1 BC patients received the LCS combination for 6 months. In these patients we examined the pharmacokinetics of sorafenib and cyclophosphamide, toxicity of the regimen, the clinical response to therapy and changes in the levels of biologically relevant biomarkers.

View Article and Find Full Text PDF
Article Synopsis
  • JMY is a protein that binds to p300 and has a dual role: it helps enhance P53 transcription to respond to DNA damage and promotes cell movement by aiding actin filament assembly in the cytoplasm.
  • Its function can vary, potentially acting as a tumor suppressor or an oncogene depending on the environment within the cell.
  • Research using a monoclonal antibody against JMY showed variable expression in normal and cancerous tissues, suggesting it may suppress tumor growth in some cases while promoting metastasis in others.
View Article and Find Full Text PDF
Article Synopsis
  • Trastuzumab improves survival for HER2 positive breast cancer patients, but resistance to treatment remains a significant issue, potentially linked to the protein ADAM17 and the other protease ADAM10.
  • In experiments, trastuzumab increased ADAM10 expression in cancer cell lines and mouse models, which was associated with reduced protein kinase B (PKB) phosphorylation and hindered treatment responses.
  • Inhibition of ADAM10 led to better responses to trastuzumab in both naive and resistant cancer cells, and higher ADAM10 levels in patients were linked to poorer treatment outcomes and relapse-free survival, suggesting ADAM10 could serve as a therapeutic target and biomarker.
View Article and Find Full Text PDF
Article Synopsis
  • TRAP1 (TNF receptor-associated protein 1) is linked to drug resistance and apoptosis in cancers like colorectal and prostate cancer, and its role was studied in non-small cell lung cancer (NSCLC).
  • The study showed that knocking down TRAP1 reduces cell growth and survival, disrupts mitochondrial functions such as ATP production, but does not change mitochondrial density or shape.
  • High levels of TRAP1 were correlated with a greater risk of disease recurrence in NSCLC patients, indicating its potential as a prognostic marker for the disease.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the role of HIF-α in regulating gene expression related to hypoxia, including processes like angiogenesis and metabolism.
  • Researchers aimed to explore posttranslational modifications of HIF-1α in tumors, finding that certain forms of hydroxylated HIF-1α are prevalent in hypoxic tumor regions.
  • The presence of these hydroxylated forms might indicate a worse prognosis for breast cancer patients, suggesting that the degradation of HIF-1α may be limited in tumors and offering new insights into cancer mechanisms.
View Article and Find Full Text PDF

The surface-enhanced hyper-Raman scattering (SEHRS) of three analyte molecules has been obtained with excitation wavelengths at 1.55 and 1.8 μm.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of calcitonin receptor-like receptor (CLR) and its ligand adrenomedullin (ADM) in tumor angiogenesis, particularly in clear cell renal cell carcinoma (RCC).
  • Researchers performed gene expression profiling and immunohistochemistry on various tumors to assess ADM and CLR levels, finding significant upregulation in RCC compared to normal tissue.
  • The findings indicate that higher CLR expression in RCC correlates with advanced tumor stages and poorer overall survival, suggesting the potential for CLR as a therapeutic target in future cancer treatment strategies.
View Article and Find Full Text PDF

Background: Non-muscle invasive (NMI) bladder cancer is characterised by increased expression and activating mutations of FGFR3. We have previously investigated the role of microRNAs in bladder cancer and have shown that FGFR3 is a target of miR-100. In this study, we investigated the effects of hypoxia on miR-100 and FGFR3 expression, and the link between miR-100 and FGFR3 in hypoxia.

View Article and Find Full Text PDF

Cyclin D1 immunostaining of non-neoplastic cells has been a source of diagnostic confusion especially in lymphoproliferative lesions. This study has reviewed these in two hundred and thirty-one haematopathological samples stained for cyclin D1. Most cases were formalin-fixed except for a few bone marrow trephines, which were B-5 fixed, and EDTA decalcified.

View Article and Find Full Text PDF

Adipocyte P2 (aP2), also known as fatty acid-binding protein 4 (FABP4), is a fatty acid-binding protein found in the cytoplasm of cells of adipocyte differentiation. In this study, we examined a large number of soft tissue tumours with a commercial polyclonal anti-aP2/FABP4 antibody and a newly developed mouse monoclonal antibody raised against this protein to determine the diagnostic utility of aP2/FABP4 as a marker of tumours of adipose differentiation. A mouse monoclonal antibody, clone 175d, was raised against a mixture of synthetic peptides corresponding to the amino acid sequence of residues 10-28 and 121-132 of the human aP2/FABP4 protein.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists found that using a drug called bevacizumab helps patients with a type of brain cancer called glioblastoma respond better to chemotherapy and live longer without the cancer getting worse.
  • However, tumors often adapt and resist the treatment, so researchers are exploring other drugs that can work well with bevacizumab to stop this resistance.
  • In their study, they discovered that combining bevacizumab with another drug called dichloroacetate (DCA) worked much better together than using either one alone, suggesting this combo could be a strong fight against brain cancer.
View Article and Find Full Text PDF